Skip to main content
Hofseth BioCare ASA logo

Hofseth BioCare ASA — Investor Relations & Filings

Ticker · HBC ISIN · NO0010598683 LEI · 5967007LIEEXZXGGEO44 OL Manufacturing
Open in API
Filings indexed 731 across all filing types
Latest filing 2025-09-04 Board/Management Inform…
Country NO Norway
Listing OL HBC

About Hofseth BioCare ASA

https://hofsethbiocare.no/

Hofseth BioCare ASA is a biotechnology company that develops and manufactures high-value nutritional ingredients from fresh Norwegian salmon off-cuts. Using a proprietary and patent-protected enzymatic hydrolysis process, the company gently extracts bioactive components, ensuring the preservation of their nutritional value. Its core products include soluble proteins (peptides), full-spectrum salmon oil, and marine calcium/collagen. These ingredients are utilized in clinically-proven finished products for both human nutrition and pet health markets, reflecting a commitment to sustainability and the full utilization of marine resources.

Recent filings

Filing Released Lang Actions
Hofseth Biocare ASA: HBC onboards former Head of Nestle Health Science Asia, Oceania, Middle East and Africa Region, Paul Bruhn
Board/Management Information Classification · 1% confidence The document announces the appointment of a new Head of New Business Development, Paul Bruhn, at Hofseth Biocare ASA. This falls under the category of senior management changes, which is explicitly defined as 'Board/Management Information' (MANG).
2025-09-04 English
Hofseth Biocare ASA: SECOND QUARTER 2025 FINANCIAL REPORT - Attachment: HBC Q2 2025 Financial report.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Second Quarter 2025 Financial Report' and contains comprehensive financial statements, including a consolidated statement of comprehensive income, statement of financial position, cash flow statement, and detailed notes to the financial statements. It covers a period shorter than a full fiscal year (Q2 2025). It is not an announcement of a report, but the report itself, containing substantive financial data and analysis. Q2 2025
2025-08-22 English
Hofseth Biocare ASA: SECOND QUARTER 2025 FINANCIAL REPORT
Earnings Release Classification · 1% confidence The document is titled 'SECOND QUARTER 2025 FINANCIAL REPORT' and provides a summary of financial performance (revenues, EBITDA, cash flow) and operational highlights for the period. While the text mentions 'Please find the HBC Q2 2025 Financial report attached', the document itself contains the actual financial data, performance metrics, and detailed business updates, which constitutes an Interim/Quarterly Report (IR) rather than just a notification of the report's existence. Q2 2025
2025-08-22 English
Hofseth Biocare ASA: HBC's ProGo® has won Ingredient of the Year for Healthy Aging at the prestigious Nutraingredients USA awards ceremony in Chicago
Regulatory Filings Classification · 1% confidence The document is a short press release announcing that Hofseth Biocare ASA's product, ProGo®, won an award ('Ingredient of the Year'). It provides details about the product, links to external news sources, and contact information. It is not a comprehensive financial report (like 10-K or IR), a transcript (CT), or a formal regulatory filing detailing share transactions or capital changes. Since it is an announcement of a specific, non-financial achievement/news item that doesn't fit the other specific categories (like DIV, CAP, ER, etc.), the most appropriate classification is the general regulatory announcement/miscellaneous category, RNS.
2025-07-16 English
Hofseth Biocare ASA: Annual General Meeting completed
AGM Information Classification · 1% confidence The document is explicitly titled "PROTOKOLL FOR ORDINÆR GENERALFORSAMLING" (MINUTES FROM ANNUAL GENERAL MEETING) in both Norwegian and English. The agenda items confirm this, covering approval of annual accounts, remuneration guidelines, election of board members, and authorization for capital increases, all standard procedures for an AGM. The document records the proceedings and resolutions of the meeting held on May 23, 2025. This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting. While it contains elements related to the Annual Report (approval of accounts), the document itself is the official record/minutes of the meeting.
2025-05-23 Norwegian
Hofseth Biocare ASA: Annual General Meeting completed
AGM Information Classification · 1% confidence The document explicitly states, "Hofseth Biocare ASA: Annual General Meeting completed" and mentions that the meeting was held on May 23, 2025. It further states, "The minutes from the Annual General Meeting are attached." Because the document is short (2592 characters) and serves primarily to announce the completion of the AGM and the availability of the minutes, it fits the description of an AGM-related announcement rather than the full minutes or a proxy statement. The most specific category is AGM Information (AGM-R).
2025-05-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.